Analjit Singh appointed non-executive Chairman of Max Financial Services

New Delhi: Max Financial Services, which houses the life insurance business of the $3-billion Max Group, has named its sponsor and founding shareholder Analjit Singh as nonexecutive chairman of the company in a filing to stock exchanges on Monday.

Singh said his appointment on the board was in consultation with current chairman Naina Lal Kidwai, who felt that as the ‘principal sponsor’ of the company he would be able to expedite decision-making. Kidwai will now continue in her role as an independent non-executive director of the company.

“I am heavily committed to India, to my businesses and my family,” Singh told ET, refuting what he termed ‘rhetoric’ about him giving up on his home turf.

The Max Group founder also ruled out speculation pertaining to his plans to exit the life insurance venture. “We are not going to exit the business. I will remain the single-largest principal sponsor,” he said.

Singh will take a four-point plan to the board of the financial services company on Friday to strengthen the life insurance business with a focus on building its proprietary distribution channels, he told ET.

Max Life Insurance Company is the largest non-bank private life insurer in India and contributes over two-thirds of Max Group’s revenues.

The company was separated as part of a demerger process involving erstwhile Max India, following which it became a subsidiary of the listed Max Financial Services.

Max India and Max Ventures and Industries are two other listed entities that resulted from the demerger. The former houses the group’s hospitals business and its health insurance joint venture with Britain’s Bupa, while the latter is the holding company for the packaging and real estate interests of the group.

Japan’s Mitsui Sumitomo Insurance is an investor in Max Life Insurance Company.

The group recorded consolidated revenues of Rs 19,151 crore in the year to March 2018, the company stated in its exchange filings. It employs 24,500 people.

  • Related Posts

    Promotion of Drug Inspectors (Medical Devices) raises hopes of Effective Regulation & Patient Safety

    AiMeD welcomes the move long overdue to boost India’s Regulatory Framework New Delhi: 21 Drug Inspectors have been promoted to Assistant Drugs Controllers (India) under CDSCO. It was long unmet…

    Yashoda Medicity lifts Benchmark in Critical Care to New High

    With the introduction of North India’s first Advanced VitalGo Total Lift Bed Technology Ghaziabad/ New Delhi: In an ideal hospital, critical care is most paramount and it is also the…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Meiji Seika to push new vaccine with SII in India

    Meiji Seika to push new vaccine with SII in India

    DGFT automates EO extension process to ease compliance for pharma exporters

    DGFT automates EO extension process to ease compliance for pharma exporters

    Udan vs Udaan: Delhi court restrains pharmaceutical firm from using ‘Udaan’ mark

    Udan vs Udaan: Delhi court restrains pharmaceutical firm from using ‘Udaan’ mark

    Three newborns die in fire at government hospital in Amravati, Maharashtra

    Three newborns die in fire at government hospital in Amravati, Maharashtra

    Maharashtra FDA to prioritise process audits for revised Schedule M compliance: FDA Commissioner

    Maharashtra FDA to prioritise process audits for revised Schedule M compliance: FDA Commissioner

    Centre bans fixed-dose combination for Common Cold in children below four

    Centre bans fixed-dose combination for Common Cold in children below four